Found 858 matching trials
Delayed Tolerance Through Mixed Chimerism PHASE1 This study will examine the safety and effectiveness of a bone marrow trans...
Show More Status
Active Not Recruiting
Location
Massachusetts General Hospital
Learn More & Join Trial
A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas PHASE1 This is a clinical trial to evaluate the feasibility and safety of giving t...
Show More Status
Active Not Recruiting
Location
Weill Cornell Medicine/NewYork-Presbyterian Hospital
Learn More & Join Trial
Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD PHASE2 Phase II multicenter, Canadian only study - open to 25 subjects. Study open...
Show More Location
Hospital Maissoneuve
Learn More & Join Trial
Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study) PHASE3 Neutropenia, a condition characterized by an abnormally low number of infec...
Show More Location
University of Iowa Hospitals and Clinics
Learn More & Join Trial
Convalescent Plasma to Limit SARS-CoV-2 Associated Complications PHASE2 To assess the efficacy and safety of Human coronavirus immune plasma (HCIP)...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT EARLY_PHASE1 The purpose of this study is to evaluate the efficacy and safety of allogen...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
RL-1 Novel Human-derived Bio-artificial Liver Treatment in Patients of HBV Related ACLF NA This study is to investigate the clinical efficacy and safety of RL-1 Novel...
Show More Location
Third Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Combined Apheresis for ABO-incompatible Transplantation - a Pilot Study NA Recipient desensitization is a prerequisite for successful ABO-incompatible...
Show More Location
Division of Medicine III, Dpt. of Nephrology and Dialysis, Medical University Vienna
Learn More & Join Trial
Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations PHASE1 This phase I trial studies the side effects and best dose of autologous CD8...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer PHASE1 This phase I clinical trial evaluates the safety and feasibility of adminis...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial